Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. Consensus
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on NOVAVAX, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) NOVAVAX, INC.
Analyst Recommendations on NOVAVAX, INC.
05/20BofA Securities Initiates Coverage on Novavax With Underperform Rating
MT
05/11B. Riley Lowers Novavax's Price Target to $181 from $203, Keeps Buy Rating
MT
04/26B. Riley Lowers Novavax's Price Target to $203 from $250, Notes Relatively Lowered Penetra..
MT
03/03HC Wainwright Adjusts Price Target on Novavax to $207 From $294, Reiterates Buy Rating
MT
03/02B. Riley Lowers Novavax's PT to $250 from $265 On Supply/Distribution, Notes Higher Near-T..
MT
02/23B. Riley Lowers Novavax's Price Target to $265 from $315 on Reduced Near-Term Estimates, M..
MT
02/15ANALYST RECOMMENDATIONS : Enbridge, GSK, PepsiCo, Moody's, Novavax...
More recommendations
Analysis
Australia says no to 16-year-old forklift drivers as remedy to COVID supply chain pain
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 46,13 $
Average target price 154,86 $
Spread / Average Target 236%
High Price Target 207,00 $
Spread / Highest target 349%
Low Price Target 35,00 $
Spread / Lowest Target -24,1%
Consensus detail
Consensus revision (last 18 months)